Dutch Healthcare Institute position on the reimbursement of molecular diagnostics in oncology

02

Jun 2021

In mid-May 2021, the Dutch Healthcare Institute (ZIN) published an advice "Molecular Diagnostics: determining the position on molecular diagnostics in oncology," which was developed at the request of the Ministry of Health, Welfare and Sport.

The objective of the position is to organize molecular diagnostics within standard regular care and develop a framework for the accessibility and integral implementation of new tests in practice. To achieve appropriate use of molecular diagnostics in oncology. It is necessary to make agreements on the organization and funding of this care with all involved parties. The framework, therefore, includes the following elements:

  • Effectiveness and location;
  • Organization of care;
  • Data infrastructure;
  • Funding.

The ZIN divided the advice into two parts. Part number one is the advice in the form of an action plan that describes the steps required. In part number two, the ZIN will work out these steps together with the involved parties.

Furthermore, on May 19, 2021, in the Letter to Dutch Parliament, the Minister of Health, Welfare and Sport asked the ZIN to take the lead in implementing the advice in collaboration with all parties involved, including monitoring of work on mutual agreements between involved parties and development of a quality standard. The timetable for implementation of the Action Plan has not been defined yet.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

27

May 2021

In April 2021, the Austrian Institute for Health Technology Assessment (AIHTA) initiated several new research projects. The projects are related to IVD tests for early detection of colon cancer, telemedical care in diabetes field, health apps, screening methods, consequences of coronavirus pandemic, and other topics.

Read more

20

May 2021

Since 2022, the Dutch Healthcare Authority (NZa) implemented four new DRGs for surgical placement and removal of a heart rhythm monitor for reimbursement of the procedure performed by the cardiopulmonary surgeon.

Read more

07

May 2021

The Dutch Healthcare Institute (ZIN) is currently evaluating the implementation of the position on Flash Glucose Monitoring (FGM) published in 2019. The publication of the results of the first interim assessment is scheduled for the fourth quarter of 2021.

Read more

29

Apr 2021

On April 20, 2021, the Dutch Healthcare Institute (ZIN) published an annual report on the progress of the conditional reimbursement program. In 2020, there were 13 ongoing projects under the program, six of which concerned medical technologies. Furthermore, in 2020, percutaneous transforaminal endoscopic discectomy for the treatment of lumbosacral radicular syndrome in lumbar disc herniation was included in the basic insurance package as regular care.

Read more

23

Apr 2021

The Dutch Organization for Health Research and Development (ZonMw) will accept applications for subsidies under the incentive scheme "eHealth at Home" until the end of 2021. This scheme is intended for digital apps that support the provision of care at home for the elderly and people with chronic illness or disability.

Read more